Charts NXS, page-11

That would be entertaining ...but I was hoping it would retrace so I could get a proper handful ...
Still I am very grateful to have any
It was up by around 18% before ...
Incredible !
And even better, Xbio sounds to be a genuine breakthrough and one that is well protected by patents.

But current prices do seem quite high.
I say this only based on the market’s tendency to play hard with exciting new ‘toys’ and a comment from month back in The Australian ( April 9) where the second last sentence says the valuation of close to $180 million is considered to be exorbitant ...
Cheers

https://www.theaustralian.com.au/bu...e/news-story/d7eb9e6eed043a6b9abad7009805c158
.... “Focused on a channel and distribution partner-led sales strategy, Next Science believes it will be able to access large global markets at low cost and scale, while focusing on ongoing research and development projects.

The company has established agreements with medical device conglomerate Zimmer Biomet or 3M to distribute wound care gel products.

Next Science generated pro-forma income of $US2.8m during the 2018 financial year and posted a net loss of $US14.8m.

The reason for the exorbitant valuation of close to $180m is the dramatic rise in sales revenues in particular over the past 12 months.... “